NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT06704724 2026-03-13A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.PfizerPhase 1 Active not recruiting30 enrolled
NCT06447662 2026-02-25A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.PfizerPhase 1 Recruiting330 enrolled
NCT04068896 2025-05-29Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyNGM Biopharmaceuticals, IncPhase 1/2 Completed89 enrolled 21 charts
NCT02103062 2020-04-21Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal CancerCelgenePhase 2 Completed41 enrolled 10 charts
NCT01730586 2020-01-18Abraxane in CIMP-High Colorectal and Small Bowel AdenocarcinomasM.D. Anderson Cancer CenterPhase 2 Completed34 enrolled 7 charts
NCT02574663 2019-10-02TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid TumorsTG Therapeutics, Inc.Phase 1 Completed66 enrolled